733
edits
No edit summary |
|||
Line 15: | Line 15: | ||
* CRTD is recommended in patients with sinus rhythm, LBBB, QRS > 120ms, EF<35%, NYHA III-IV. IA <cite>ESCHF</cite><cite>ESCfocusedup</cite> | * CRTD is recommended in patients with sinus rhythm, LBBB, QRS > 120ms, EF<35%, NYHA III-IV. IA <cite>ESCHF</cite><cite>ESCfocusedup</cite> | ||
* CRT in patient with an other Class I pacemaker indication who is in NYHA III/IV, LVEF ≤35%, QRS ≥120 ms. IB<cite>ESCsyncope</cite> | * CRT in patient with an other Class I pacemaker indication who is in NYHA III/IV, LVEF ≤35%, QRS ≥120 ms. IB<cite>ESCsyncope</cite> | ||
* | * Syncope, documented VT and structural heart disease. IB <cite>ESCsyncope</cite> | ||
* When monomorphic VT is induced at EP study in patients with previous myocardial infarction. IB <cite>ESCsyncope</cite> | * When monomorphic VT is induced at EP study in patients with previous myocardial infarction and syncope. IB <cite>ESCsyncope</cite> | ||
==Class IIa (should be considered)== | ==Class IIa (should be considered)== |